Finex (Finasteride)

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Finex (Finasteride)

Finex is a synthetic, prescription-only medication containing the active ingredient Finasteride, an orally active compound specifically classified as a 5-alpha reductase inhibitor. This drug is solely intended for use in adult males, and its core identity is rooted in its selective biochemical mechanism that targets specific hormonal processes.

Property Description
Active ingredient Finasteride
Form Oral tablet (typically film-coated)
Pharmacological class 5-alpha reductase inhibitor (antiandrogen)
Common purpose To reduce Dihydrotestosterone (DHT) concentration
Origin Synthetic (4-azasteroid compound)

What Type of Medicine is Finasteride (Finex)?

Finasteride is a single-ingredient, synthetic drug categorized within the pharmacological class of 5-alpha reductase inhibitors. Structurally, this compound is identified as a 4-azasteroid, a distinctive chemical classification. The unique feature of Finasteride is its selective inhibition of the Type II 5alpha-reductase enzyme, a targeted action that is clinically recognized for its predictable impact on the body's androgen metabolism.

Composition and Form: The Selective Inhibitor

The composition of Finex is centered on the active compound Finasteride, which is delivered as an oral tablet for systemic administration in men. This solid, film-coated dosage form ensures a consistent, measured dose is taken by mouth, establishing the required oral route of administration for systemic absorption. The reliable use of this tablet formulation is essential for maintaining the continuous enzymatic inhibition required for the drug's effect.

General Purpose: Modulating Dihydrotestosterone (DHT)

The fundamental utility of Finasteride is to produce a sustained antiandrogenic effect by interfering with a key hormonal conversion pathway. It achieves this by precisely blocking the action of the Type II 5alpha-reductase enzyme, which prevents the conversion of the male hormone Testosterone into the significantly more potent androgen, Dihydrotestosterone (DHT). The resulting suppression of DHT concentration is the foundational biological consequence, used to mitigate physiological processes that are driven by the presence of this hormone.

What side effects are possible with Finex (Finasteride)?

Possible Side Effects and Safety Information

The officially documented safety profile for Finasteride is characterized by adverse reactions primarily affecting the reproductive and psychiatric systems. These effects are classified by frequency as observed in clinical use and post-marketing surveillance, as documented by regulatory bodies.

Frequency-Classified Adverse Reactions

Adverse reactions are grouped based on the frequency reported in official regulatory documents:

  • Common (may affect up to 1 in 10 men): Decreased libido (sexual desire) and Erectile dysfunction.
  • Uncommon (may affect up to 1 in 100 men): Ejaculation disorders (e.g., decreased volume of ejaculate), breast tenderness and/or enlargement (gynecomastia), and skin rash.

Serious Safety Concerns

Regulatory agencies have documented reports of clinically significant events, some of which are classified with a frequency of Not Known (frequency cannot be estimated from available data):

  • Serious Adverse Reactions include hypersensitivity reactions (such as angioedema) and the reporting of male breast cancer.
  • Psychiatric Effects such as depression have been reported.
  • The label notes an association with high-grade prostate cancer in men treated for Benign Prostatic Hyperplasia (BPH) in clinical studies.
  • Persistent sexual adverse reactions have been reported to continue in some men even after discontinuing the medicine.

Population Restrictions and Limitations

Finasteride is contraindicated in women (especially those who are or may be pregnant) and pediatric patients. The drug is known to be extensively metabolized in the liver, and caution is noted for men with hepatic impairment. The tablet should not be handled by women who are or may be pregnant due to the risk of absorption and potential harm to a male fetus.

Overdose and Emergency Response

Overdose and when to seek help — official regulatory information for Finex (Finasteride)

Overdose Scope Official Regulatory Statement
Documented Manifestations No specific adverse symptoms or clinical signs were formally documented in regulatory labeling following single doses up to 400 mg or multiple daily doses up to 80 mg for three months.
Physiological Systems Affected Regulatory documents do not describe specific physiological system failures or severe/life-threatening outcomes explicitly attributed to acute overdose.
Dose-Related Factors Clinical experience included high-dose exposure, demonstrating that even levels significantly above the standard therapeutic dose were well tolerated in studies.
When to Seek Help Urgent medical attention should be sought for any suspected overdose. For management guidance, contact your regional poison control centre immediately.

Overdose Treatment Protocol

Protocol Detail Statement from Official Regulatory Sources
Antidote Availability No specific treatment or antidote is recommended for the management of Finasteride overdose.
Procedural Measures Until further experience is obtained in overdose situations, management is anticipated to be symptomatic and supportive.

Connection to the Official Overdose Profile

The official regulatory documentation defines the overdose profile primarily by the documented absence of acute symptoms in high-dose human exposures, indicating that a specific, acute adverse syndrome is not established. This high tolerability results in a regulatory profile that mandates seeking urgent medical attention and contacting specialized external guidance immediately. The resulting emergency management protocol is limited to providing generalized symptomatic and supportive treatment, a recommendation that directly reflects the regulatory conclusion that no specific antidote is available.

Therapeutic Uses of Finex (Finasteride)

Finasteride is a therapy used for adult men in situations involving certain distressing symptoms. This therapy is commonly used to help with long-term symptomatic management and maintaining functional stability as the conditions progress. The medication is relevant in clinical settings involving urological and dermatological symptom patterns.

Finasteride is applied across domains where additional symptomatic support is needed to manage symptoms related to Benign Prostatic Hyperplasia (BPH) and Male Pattern Hair Loss (Androgenetic Alopecia). In BPH, it is used for managing groups of symptoms that may become intense or disruptive, such as a weak stream and disruptive nighttime waking to urinate (nocturia). The medication supports the patient during difficult episodes and assists with maintaining functional stability by managing symptoms that interfere with daily functioning.

Applied in clinical settings that involve androgenetic hair thinning, it may assist in slowing the progression of symptoms that create noticeable physiological strain, and supports the patient by contributing to symptomatic relief, helping to maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relief for BPH Quick Fact: Relief for Hair Loss
Supports the reduction of prostate volume to ease obstructive urinary flow symptoms. Helps manage symptoms related to progressive hair thinning and miniaturization on the scalp.

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Official Population Eligibility for Finex (Finasteride)

The use of Finasteride is strictly defined by regulatory authorities and is indicated for use in adult men only.

Population Eligibility Status Regulatory Basis
Females (Women) Contraindicated/Not Indicated Use is prohibited, particularly in pregnant females due to the risk of fetal abnormalities. Women must not handle crushed or broken tablets.
Pediatric Patients Not Indicated for Use Safety and effectiveness have not been established in patients under 18 years of age.
Hypersensitivity Contraindicated Prohibited for individuals with known hypersensitivity to the active substance or any excipients.

Condition-Specific and Age Restrictions

Use requires caution in patients with liver function abnormalities, as the drug is extensively metabolized. Conversely, for individuals with renal impairment or older men (Geriatric Use), no dosage adjustment is necessary as per the official regulatory documentation. Patients with severely diminished urinary flow must be carefully monitored for obstructive issues.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Finasteride is primarily defined by specific regulatory restrictions and its metabolic pathway, with most co-administered agents showing no clinically meaningful interaction.

Co-Administration Restrictions and Prohibited Combinations

Co-administration with other 5-alpha reductase inhibitors (such as dutasteride) is prohibited by regulatory authorities. This restriction is due to the potential for duplication of therapy and additive effects, and is classified as a formal restriction for use.

Pharmacokinetic and Exposure Interactions

Finasteride is primarily metabolized by the Cytochrome P450 3A4 (CYP3A4) enzyme system. Although Finasteride itself does not significantly inhibit or induce the CYP450 system, it is probable that strong CYP3A4 inhibitors or CYP3A4 inducers will alter the drug’s plasma concentration. However, based on the established safety margin, any resulting changes are generally not classified as clinically important interactions.

In studies with common co-administered medicines, no clinically meaningful interactions were found with agents including Digoxin, Warfarin, Propranolol, and Theophylline.

Food, Herbal Products, and Population Notes

There is no documented, clinically significant interaction with food; Finasteride may be taken with or without meals. The herbal product St John's Wort, a known CYP3A4 inducer, may potentially decrease Finasteride's plasma levels. Furthermore, regulatory documents note that the effect of hepatic insufficiency on Finasteride’s pharmacokinetics has not been formally studied, advising caution in this patient population.

Mechanism of Action

Finasteride is a selective competitive inhibitor that acts directly on the Type II 5-alpha reductase (5alpha-R) enzyme. This enzyme is responsible for catalyzing the conversion of Testosterone into the more potent androgen, Dihydrotestosterone (DHT). The drug binds to the enzyme's active site, forming a stable, time-dependent complex that blocks its catalytic function in tissues where Type II 5alpha-R predominates, such as specific hair follicles and the prostate gland.

This molecular inactivation initiates a cascade leading to a measurable reduction in both circulating and tissue concentrations of DHT. The decrease in this potent androgenic ligand alters the hormonal stimulus for cellular activity in DHT-dependent tissues. Additionally, Finasteride inhibits 5alpha-R activity in the central nervous system, where the enzyme produces neurosteroids that modulate GABA A receptors. This secondary action results in an altered concentration of these inhibitory mediators, contributing to the full physiological profile of the drug's mechanism.

Dosage and Administration Information

Official Administration Guidelines for Finex (Finasteride)

Finasteride is administered solely by the oral route as a film-coated tablet and is approved only for use in adult men. The administration pattern is determined by the specific clinical context, adhering to two distinct daily dose strengths.


Standard Labeled Dosing Regimens

Indication (High-Level Use Pattern) Standard Adult Daily Dose Labeled Strength
Benign Prostatic Hyperplasia (BPH) One 5 mg tablet daily 5 mg
Male Pattern Hair Loss (Androgenetic Alopecia) One 1 mg tablet daily 1 mg

Administration Conditions and Duration

Finasteride must be taken once daily (qDay) to maintain continuous systemic levels. The daily dose may be taken with or without food, simplifying the required schedule for long-term use. The tablet should be swallowed whole and must not be crushed or broken.

Official prescribing information specifies that treatment is typically long-term and continuous. For both usage patterns, several months of continuous daily administration—often six months or more—are required before a full assessment of the response can be made. If a dose is missed, patients are generally instructed to skip the missed dose and resume the schedule with the next dose at the regular time, without taking a double dose.

Use in Specific Populations

No dosage adjustment is required for older adults (geriatric patients) or in patients with mild to moderate renal impairment. The use of Finasteride is not approved for children or adolescents.

Recent Clinical Evidence

Recent Clinical Evidence

Core Efficacy Trials (Oral Finasteride)

Clinical trials have long established the use of finasteride (1 mg) in men for the management of androgenetic alopecia (male pattern hair loss) and finasteride (5 mg) for benign prostatic hyperplasia (BPH). Pivotal Phase 3 studies demonstrated that the drug affected hair loss progression and hair count compared to placebo at 12 months. Long-term research, including trials up to five years, suggests that continued use is associated with maintaining the initial changes and slowing further progression of hair loss.

For BPH, the 5 mg dose has been consistently associated with a reduction in prostate volume and an improvement in urinary symptoms in multi-year trials, alongside a reduced risk of acute urinary retention and the need for related surgery.


Safety Profile and Ongoing Research

Studies over the past two decades have monitored the long-term safety of finasteride. The most commonly reported side effects across both doses relate to sexual dysfunction, including decreased libido, erectile dysfunction, and ejaculatory disorder, occurring in a small percentage of trial participants (often comparable to placebo rates, but with a statistically significant increase in some studies).

Recent analysis from safety databases and post-marketing surveillance highlights ongoing clinical discussion regarding the potential for these sexual and certain neuropsychiatric effects (e.g., depression) to persist in some individuals after discontinuing treatment. This area continues to be the subject of clinical research and regulatory review.


Emerging Data on Topical Formulations

Recent Phase 3 clinical trials have focused on topical finasteride formulations to investigate whether local application can reduce systemic exposure while maintaining efficacy for androgenetic alopecia. Preliminary data from these trials indicates that topical spray solutions may provide a statistically significant change in hair count compared to placebo, with markedly lower plasma finasteride concentrations and less impact on serum DHT levels compared to the oral route.

Key Studies & References

  1. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Finex (Finasteride) (FAQ)


Q: How long does it typically take to see any effects from Finasteride?

A: Official product information indicates that continuous daily use for several months is generally required before the drug's full effect can be properly assessed. Studies often require six months or more of continuous daily administration. Maintaining the beneficial effects typically requires continued use of the medicine.


Q: What happens if I stop taking Finasteride suddenly?

A: The medicine is generally intended for long-term, continuous use. Official documents and studies indicate that if treatment is discontinued, the effects the drug had on the condition are usually reversed over time. Discontinuing the medicine is generally associated with the condition gradually returning to its state prior to the start of treatment.


Q: Is it true that Finasteride can affect PSA test results?

A: Yes, regulatory documents note that Finasteride reduces the level of Prostate-Specific Antigen (PSA) in the bloodstream. This reduction is generally around 50% after six months of treatment. Healthcare providers must account for this change when they interpret a patient's PSA test results.


Q: What is 'Post-Finasteride Syndrome' and is it officially recognized?

A: Post-marketing surveillance reported in official product labels notes that persistent sexual adverse reactions and certain psychiatric effects have been observed in some individuals after they stop taking the medicine. These effects, including decreased libido, erectile dysfunction, and depression, have been reported to continue after discontinuation.


Q: Is Finasteride a steroid or a hormone?

A: Finasteride is chemically described as a synthetic 4-azasteroid compound and belongs to a pharmacological class of medicine called a 5-alpha reductase inhibitor. It works by interfering with the body’s processing of the male hormone Testosterone into a more potent form, Dihydrotestosterone (DHT).


Q: How is Finex different from other hair loss treatments like Minoxidil?

A: Finasteride is classified as a 5-alpha reductase inhibitor, meaning it works internally by blocking an enzyme that creates Dihydrotestosterone (DHT). Regulatory documents classify Minoxidil under a different pharmacological class. Finasteride's primary mechanism is related to internal hormonal processes.


Q: Can women use Finex (Finasteride)?

A: No. Official documents strictly contraindicate the use of Finasteride in women. This restriction is particularly critical for women who are or may be pregnant, due to the potential risk of harm to a male fetus.


Q: Does Finex interact with common painkillers like ibuprofen?

A: Clinical studies did not show any clinically significant interactions when Finasteride was co-administered with common nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or with acetaminophen. Official labels do not list these common painkillers as restricted combinations.


Q: Can Finex affect my ability to donate blood?

A: Official blood donation guidance may include recommendations concerning donor eligibility while taking Finasteride or for a specific time after discontinuation. This guidance is in place due to regulatory concerns regarding the drug's effect on a developing male fetus.


Q: Are there any specific foods or drinks to avoid while taking Finex?

A: Official prescribing information states that Finasteride may be taken with or without food. No specific dietary restrictions or avoidance of certain foods or drinks are noted in the official product label.


Q: Can Finex be used by someone with a history of liver issues?

A: Finasteride is known to be metabolized extensively in the liver. Official documents note that caution is required in patients with liver function abnormalities, as the medicine is metabolized extensively in the liver.


Q: Does Finex affect fertility in men?

A: Official documents note that reports of infertility, as well as poor semen quality (including low sperm count), have occurred in men using Finasteride. In some of these cases, improvement in semen quality has been reported after stopping the medication.


Q: Is Finex available over the counter in some countries?

A: In the United States and territories governed by major regulatory bodies, the active ingredient Finasteride is classified as a prescription-only medication. Drug classifications can vary by country, and Finasteride is generally classified as a prescription drug.


Q: Does Finasteride interact with herbal supplements?

A: The official product label notes a potential interaction with the herbal product St John's Wort. This supplement is classified as an enzyme inducer and may potentially decrease the concentration of Finasteride in the bloodstream.


Q: Can Finex cause changes in mood or lead to depression?

A: Yes. Official post-marketing surveillance reports note that depression and depressive symptoms have been reported as potential side effects. These psychiatric effects have also been reported to persist in some men after discontinuing treatment.


Q: Are there restrictions on handling Finasteride tablets for partners or family members?

A: Yes. Official regulatory instructions state that women who are or may potentially be pregnant must not handle crushed or broken Finasteride tablets. This is due to the potential risk of absorption and subsequent harm to a male fetus.


Q: Can older men still use Finasteride for hair thinning?

A: Finasteride is indicated for use in adult men for hair loss. Regulatory guidelines for the higher 5 mg dose confirm that no dosage adjustment is required for older men. It is generally indicated for use in adult men regardless of age.


Q: What is the common age range for people starting Finasteride?

A: The drug is officially indicated for use only in adult men. Official documents state that safety and effectiveness have not been established in patients under 18 years of age. The drug is indicated exclusively for use within the adult population.


Q: Is Finex approved for hair loss in non-male individuals?

A: No. The official indication for the medicine is for use only in adult men. It is specifically contraindicated (prohibited) for use in women.


Q: Can Finex affect blood pressure?

A: Official clinical trial results and product labels do not list changes in blood pressure as a common or uncommon adverse reaction. The drug was generally well-tolerated in clinical studies.


Q: Do I need to take Finasteride forever to maintain effects?

A: Official product information states that the treatment is typically long-term and continuous. Studies indicate that if a patient stops the treatment, the beneficial effects on the condition are usually reversed within approximately one year.


Q: Can men with a family history of prostate cancer use Finasteride?

A: Official warnings note that Finasteride use may increase the risk of high-grade prostate cancer in men taking the 5 mg dose. However, a family history of prostate cancer is not listed as a contraindication. The label emphasizes the need for PSA monitoring during use.


Q: Are there generic versions of Finex available?

A: Yes. The active ingredient, Finasteride, is available under various generic and brand names, as confirmed by official drug listings. Official drug listings confirm the existence of various generic versions.


Q: Does Finasteride make existing hair thicker?

A: Clinical trials demonstrated that Finasteride increased hair count and helped slow the progression of hair loss. These findings are consistent with an improvement in the overall density and appearance of the hair.


Q: What are the known severe, but rare, side effects of Finasteride?

A: Official regulatory documents have reported serious adverse reactions that are severe but rare. These include hypersensitivity reactions, such as angioedema (swelling beneath the skin), reports of male breast cancer, and the reporting of high-grade prostate cancer in certain studies.


Q: How soon after stopping Finex do the effects wear off?

A: Studies on drug discontinuation show that the beneficial effects on the condition are generally reversed within approximately one year after stopping the treatment. The condition is expected to gradually return to the pre-treatment state.

How should Finex (Finasteride) be stored and disposed of?

How to Store and Dispose of Finasteride

Finasteride tablets must be stored according to regulatory requirements to ensure stability and safety. The medication requires storage at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The product must be kept in its original, tightly closed container and protected from both light and moisture. Always store the tablets out of the sight and reach of children.

Special Handling and Disposal

Finasteride tablets are film-coated; however, a critical regulatory instruction mandates that women who are pregnant or may potentially be pregnant must not handle crushed or broken finasteride tablets. This instruction is based on the potential risk to a male fetus.

Disposal of any unused or expired product must be done in accordance with local requirements. The preferred method is typically a drug take-back program. Finasteride should not be flushed down a toilet or drain unless specifically authorized by the official label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Finex (Finasteride) found in:

A-Z Index: